Ortataxel
Ortataxel is a drug used in chemotherapy. As of June 2009, Spectrum Pharmaceuticals has the drug in a Phase 2 clinical trial.
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ECHA InfoCard | 100.158.836 |
Chemical and physical data | |
Formula | C44H57NO17 |
Molar mass | 871.92 g/mol g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.